Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
104.88
+1.18 (1.14%)
At close: Oct 26, 2026, 4:00 PM EDT
104.60
-0.28 (-0.27%)
After-hours: Oct 26, 2026, 7:56 PM EDT
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Strong Buy" and an average price target of $118.52. The average 1-year stock price forecast is 13.01% higher than the current stock price, while the lowest is $100 (-4.65%) and the highest is $130 (+23.95%).
Price Target: $118.52 (+13.01%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Abbott Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 17 | 16 | 17 | 18 | 19 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 7 | 7 | 7 | 6 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 28 | 27 | 27 | 27 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Buy Maintains $124 → $120 | Buy | Maintains | $124 → $120 | +14.42% | Oct 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $120 | Buy | Maintains | $120 | +14.42% | Oct 22, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $115 | Buy | Maintains | $115 | +9.65% | Oct 22, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $135 → $118 | Buy | Reiterates | $135 → $118 | +12.51% | Oct 22, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $130 → $125 | Buy | Reiterates | $130 → $125 | +19.18% | Oct 22, 2026 |
Financial Forecast
Revenue This Year
49.96B
from 44.33B
Increased by 12.71%
Revenue Next Year
53.53B
from 49.96B
Increased by 7.13%
EPS This Year
5.52
from 5.15
Increased by 7.17%
EPS Next Year
5.94
from 5.52
Increased by 7.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.